Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07270809

To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.

Title - To study the clinical course and outcomes of non-electively hospitalised patients of chronic liver disease (CLD) with Hepatic or Extra-hepatic predominant organ failure(s) at 6 months.

Summary - ACLF is a condition where acute insult leading to worsening liver failure with or without extra-hepatic failure leads to a high short-term mortality. However, the presence of cirrhosis, prior decompensation, non-hepatic/systemic acute insult, organ failure and treatment are different in different part of the world. This is due to in-homogenous patient cohort. The current study was planned for all patients of CLD, who were non-electively hospitalized and were followed up for long-term to identify the differences in clinical course, acute insult, organ failure, therapy and outcome in relation to liver failure with or without extra-hepatic organic failure. In the study the laboratory, clinical parameters, inflammatory and regenerative markers will be evaluated as a marker of disease progression, reversal, recompensation or regression. This will enable us to differentiate the ACLF between east and west, guide us for defining the natural course of CLD with failure.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Institute of Liver & Biliary Sciences (ILBS)

New Delhi, National Capital Territory of Delhi, 110070, India

Location contact

Dr Amanjot Kaur, MD

CONTACT

[email protected]

01146300000

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-70 years
  • CLD with or without cirrhosis with 1st or subsequent admissions for decompenasation and irrespective of any prior decompensation
  • Non-electively hospitalized

Exclusion criteria

  • HCC
  • NCPF/EHPVO
  • Pregnancy
  • Post-Liver transplant

Treatment and study plan

No intervention

Other

No Intervention

Primary outcomes

  1. Death or liver transplant at 6 months follow up.

    Time frame: 6 months

Secondary outcomes

  1. Recovery as per disease severity scores, i.e- decrease in MELD ≥5 and CTP ≥3

    Time frame: 6 months

  2. Organ dysfunction and organ failures

    Time frame: day 28, day 90, day 180

Study contacts

Contact information is provided by the study sponsor or research team.

Dr Amanjot Kaur, MD

CONTACT

[email protected]

01146300000

Dr Ashok Chaoudhury, DM

CONTACT

[email protected]

01146300000

Sponsors and collaborators

Lead sponsor

Institute of Liver and Biliary Sciences, India

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 8, 2025
Registry last updated
Dec 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.